Imexhs Ltd · ASX:IME
Imexhs — Morgans Technology Conference 2021
21 slides from Imexhs's conference presentation, Nov 24, 2021
Slide 1: ASX Announcement: Morgans Technology Conference
24 November 2021 ASX ANNOUNCEMENT For personal use only Morgans Technology Conference Attached are the presentation slides which will be delivered at the Morgans Technology Conference at 11.40 am today. Authorised for release by the Chairman of IMEXHS Limited. -ENDS- For more information, please con
Slide 2: Built by physicians for physicians
For personal use only Built by physicians for physicians Morgans Technology Conference 24 November 2021
Slide 3: Innovative provider of cloud-based, AI medical imaging software solutions
For personal use only Innovative provider of cloud-based, AI medical imaging software solutions IMEXHS LTD (ASX:IME) | MORGANS TECHNOLOGY CONFERENCE 2
Slide 4: Expanding global footprint
Expanding global footprint For personal use only Spain 15 countries USA 310 sites Mexico 2,100+ radiologists Honduras El Salvador Nicaragua Australia Costa Rica Panama Colombia 25 distributors Ecuador Peru Brazil Bolivia ~95% Paraguay customer retention Chile Uruguay IMEXHS currently operating 38 Ar
Slide 5: IMEXHS medical imaging platform
IMEXHS medical imaging platform For personal use only Advanced Stella Vital Alma Braviz Post-processing AI 3D ADv 3D Basic Enterprise Aquila Alula Anteros Imaging Radiology Pathology Cardiology Core Platform HIRUKOTM Universal Portals Multi-Tenancy PACS/VNA Viewer Nuance 360 IMEXHS LTD (ASX:IME) | M
Slide 6: Our competitive advantage
Our competitive advantage For personal use only ACCESSIBILITY CAPABILITY FLEXIBILITY AFFORDABILITY • Fully web & cloud-based • Single platform and • Multi-modality • Lower cost base than • Teleradiology accessed archiving system • Scalable modular solutions competitors from any device or browser • M
Slide 7: Q3 YTD FY21 Financial Highlights
Q3 YTD FY21 Financial Highlights1 For personal use only Sales Revenue Annual Recurring Revenue Closing cash $8.7m $13.1m $6.2m Up 30% yoy, up 40% on a Up 46% yoy, up 56% on a $8.3m at 30 June 2021 constant currency basis2 constant currency basis2 Includes a one-off sale of Includes 93 active Aquila
Slide 8: Strong growth in ARR
Strong growth in ARR For personal use only ARR as at 30 September 2021 • $13.1m, up 46% vs pcp (56% on a constant currency basis) • Includes $11.0m from Aquila Custom and $2.1m from Aquila in the Cloud (AiC) Constant currency basis assumes that historic results are converted at the average FY21 exch
Slide 9: Aquila Custom
Aquila Custom For personal use only • Customised enterprise imaging platform for radiology, can include hardware and reporting • Dedicated to large university hospitals and +41% multi-site healthcare organisations in LATAM +30% • Average contract length ~ 5 years • 73 customers; 3.75m studies • ARR
Slide 10: Aquila in the Cloud (AiC)
Aquila in the Cloud (AiC) For personal use only • Standardised radiology solution launched in May 2020 • Provides small and medium-sized customers in with affordable product offering, sold in US$’s • At 30 September 2021, 93 deals signed with ARR contribution of $2.1m • 6 deals in the US and 4 in Au
Slide 11: Developing AI capabilities
Developing AI capabilities For personal use only • Images almost doubled to 940m reflecting Number of Images Stored (m) full year of Colsubsidio contract 940 • Important test bed for the development and training of AI tools • Developed Stella AI engine which 488 integrates own and third party AI alg
Slide 12: Strategy & Outlook
For personal use only Strategy & Outlook 11
Slide 13: Global market opportunity
Global market opportunity For personal use only • IMEXHS’s main market is currently RIS/PACS Market 1 Colombia, third largest LATAM country • 85% of AiC3 deals Put bulletfrom outside Colombia points 2019 US$2.8bn • and text here US accounts for ~40% of the global radiology imaging systems (RIS) and
Slide 14: Industry Trends: Healthcare IT sector
INDUSTRY TRENDS: Healthcare IT sector For personal use only Increasing use of Increased proportion Large, growing but radiological Chronic global of the value chain Shift from client highly fragmented techniques in wider radiologist shortage coming from server architecture to global medical clinical
Slide 15: Acquisition of RIMAB
Acquisition of RIMAB For personal use only • On 5 October 2021, IMEXHS acquired RIMAB SAS, a radiology services ~40 radiologists provider, for COP24.3bn (~A$8.5m1) less highly skilled workforce estimated purchase price adjustments 2020 Revenue • RIMAB was co-founded in 2012 by A$9.0m1, 2 IMEXHS CEO
Slide 16: Benefits of a Combined Group
Benefits of a Combined Group For personal use only FUTURE RADIOLOGY CHAIN Patient Scan PACS1 The role of technology in radiology, in particular AI, Physician In-house Cloud will increase in the future. Full process of image/report transfer powered by software • RIMAB provides IMEXHS with Artificial
Slide 17: RIMAB Update
RIMAB Update For personal use only RIMAB unaudited 1H FY21 results: • 2H contract win previously announced: • Revenue ~$5.3m up 40%(1) vs pcp University Hospital of Santander, with run rate monthly revenues of circa A$50,000 • EBITDA ~$0.7m up 25%(1) vs pcp • Spanish customer HealthTime generating R
Slide 18: FY2021 Outlook
FY2021 Outlook For personal use only Aquila Custom - strong near-term US expansion – building presence with pipeline for larger customised AiC, sales team investment and via online solutions marketplaces Aquila in the Cloud (AiC) – strong Investing in growth – Sales, technology underlying demand and
Slide 19: Q&A
For personal use only Q&A 18
Slide 20: Glossary
Glossary For personal use only Artificial intelligence (AI) tools aid the Medical verticals are market segments Streaming technology transfers medical interpretation of radiological images that refer to specific diagnostic images from our VNA to our Web Viewer, which require access to large image de
Slide 21: Disclaimer
Disclaimer For personal use only The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipie